Newer developments in the treatment of Gram-positive infections

Expert Opinion on Pharmacotherapy
Pornpan KoomanachaiDavid P Nicolau

Abstract

Gram-positive organisms are continually a major cause of infection. These organisms are ever-evolving and exhibit resistance to nearly all available agents. Historically, vancomycin was crowned the drug of choice for many of these organisms including methicillin-resistant Staphylococcus aureus, penicillin-resistant Streptococcus pneumoniae, and penicillin-resistant Enterococcus spp. Many of these organisms have exhibited reduced susceptibility or frank resistance to vancomycin which has resulted in treatment failure. For this reason, new strategies in treating Gram-positive infections are a hot topic. There are two general approaches to waging this war: i) development of new antimicrobial agents; and ii) reinvigorating old antibiotics that still retain appreciable activity against Gram-positives. We review both antibiotic groupings with a focus on S. aureus, S. pneumoniae and Enterococcus spp.

References

Jun 1, 1984·The Journal of Antimicrobial Chemotherapy·N ClumeckB Gordts
Apr 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T G CantúP S Lietman
Oct 1, 1996·Trends in Microbiology·M ArthurP Courvalin
Oct 21, 1999·International Journal of Antimicrobial Agents·K Christiansen
Oct 21, 1999·International Journal of Antimicrobial Agents·M Whitby
Oct 21, 1999·International Journal of Antimicrobial Agents·J Turnidge, P Collignon
Oct 21, 1999·International Journal of Antimicrobial Agents·D Spelman
Oct 21, 1999·International Journal of Antimicrobial Agents·M Whitby
Oct 29, 2000·Seminars in Respiratory Infections·J M Blondeau, G S Tillotson
May 17, 2001·Antimicrobial Agents and Chemotherapy·A L BarryS D Brown
Jul 4, 2001·Clinical Pharmacokinetics·W J BurmanC Peloquin
Jan 10, 2003·Molecular Microbiology·Silke BesierThomas A Wichelhaus
Feb 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George M Eliopoulos
Feb 18, 2003·Archives of Internal Medicine·Philip A MastersNirmal Joshi
Jun 17, 2003·Biological & Pharmaceutical Bulletin·Takuya IwamotoMichio Kojima
Jun 25, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Graeme R NimmoUNKNOWN AGAR
Jul 25, 2003·Antimicrobial Agents and Chemotherapy·Jared A SilvermanHoward M Shapiro
Oct 9, 2003·Clinical Pharmacokinetics·Dennis J Stalker, Gail L Jungbluth
Oct 30, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Elyse SeltzerUNKNOWN Dalbavancin Skin and Soft-Tissue Infection Study Group
Jun 17, 2004·Journal of Clinical Pharmacology·Barry Dvorchik
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Anne Schmitt-HoffmannPéter Kovács
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·Sharath S HegdeJ Kevin Judice
Jan 26, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Issam RaadElyse Seltzer
Feb 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN Infectious Diseases Society of America
Apr 22, 2005·Journal of Molecular Biology·Sebastian HanssonDerek T Logan
Apr 22, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jorg J RuheAnupama Menon
May 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin E StryjewskiUNKNOWN FAST Investigator Group
May 18, 2005·The Journal of Infectious Diseases·Jared A SilvermanJeff Alder
Aug 16, 2005·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Sarvajna SacchidanandGilbert Rose
Aug 27, 2005·The Journal of Antimicrobial Chemotherapy·David M Livermore
Oct 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Luis E JaureguiWilliam O'Riordan
Dec 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lance R Peterson
Feb 24, 2006·Antimicrobial Agents and Chemotherapy·Martin E StryjewskiUNKNOWN FAST 2 Investigator Group
Mar 10, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P C Appelbaum
Jun 30, 2006·Expert Opinion on Pharmacotherapy·Su Young LeeDavid P Nicolau

❮ Previous
Next ❯

Citations

Feb 23, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Victor Nizet
Jun 25, 2010·The Pediatric Infectious Disease Journal·Bindiya Bagga, Jerry L Shenep
Dec 18, 2010·Future Microbiology·Rasmus V RasmussenNiels E Bruun
Aug 29, 2012·Expert Opinion on Drug Delivery·Abhinay SharmaAtul Kumar Johri
Aug 30, 2011·Current Opinion in Microbiology·Daniela Jabes
Mar 26, 2011·Annals of the New York Academy of Sciences·Karen L LeachPaul F Miller
Nov 20, 2021·Medicinal Research Reviews·Vladimir VimbergGabriela B Novotná

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved